協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/04/08 | 3,290 | 3,310 | 3,220 | 3,285 | +35 | +1.1% | 715,600 |
| 2021/04/07 | 3,275 | 3,290 | 3,215 | 3,250 | -55 | -1.7% | 1,381,000 |
| 2021/04/06 | 3,350 | 3,370 | 3,300 | 3,305 | -45 | -1.3% | 694,600 |
| 2021/04/05 | 3,370 | 3,395 | 3,320 | 3,350 | +20 | +0.6% | 620,700 |
| 2021/04/02 | 3,280 | 3,335 | 3,260 | 3,330 | ±0 | ±0% | 604,300 |
| 2021/04/01 | 3,350 | 3,365 | 3,305 | 3,330 | +20 | +0.6% | 848,100 |
| 2021/03/31 | 3,260 | 3,335 | 3,240 | 3,310 | +35 | +1.1% | 938,600 |
| 2021/03/30 | 3,345 | 3,350 | 3,260 | 3,275 | ±0 | ±0% | 658,100 |
| 2021/03/29 | 3,330 | 3,330 | 3,230 | 3,275 | -5 | -0.2% | 1,017,700 |
| 2021/03/26 | 3,215 | 3,305 | 3,185 | 3,280 | +110 | +3.5% | 984,200 |
| 2021/03/25 | 3,150 | 3,190 | 3,130 | 3,170 | +50 | +1.6% | 767,900 |
| 2021/03/24 | 3,125 | 3,160 | 3,095 | 3,120 | -25 | -0.8% | 1,059,600 |
| 2021/03/23 | 3,180 | 3,190 | 3,120 | 3,145 | -55 | -1.7% | 1,016,500 |
| 2021/03/22 | 3,195 | 3,225 | 3,175 | 3,200 | -20 | -0.6% | 634,400 |
| 2021/03/19 | 3,180 | 3,245 | 3,180 | 3,220 | +40 | +1.3% | 1,658,700 |
| 2021/03/18 | 3,120 | 3,200 | 3,120 | 3,180 | +65 | +2.1% | 887,800 |
| 2021/03/17 | 3,100 | 3,120 | 3,085 | 3,115 | -35 | -1.1% | 1,082,100 |
| 2021/03/16 | 3,175 | 3,195 | 3,130 | 3,150 | -70 | -2.2% | 1,134,100 |
| 2021/03/15 | 3,195 | 3,225 | 3,160 | 3,220 | +20 | +0.6% | 666,200 |
| 2021/03/12 | 3,195 | 3,210 | 3,155 | 3,200 | +25 | +0.8% | 1,429,300 |
| 2021/03/11 | 3,195 | 3,210 | 3,155 | 3,175 | -25 | -0.8% | 1,002,900 |
| 2021/03/10 | 3,200 | 3,230 | 3,155 | 3,200 | -20 | -0.6% | 877,400 |
| 2021/03/09 | 3,300 | 3,300 | 3,195 | 3,220 | -20 | -0.6% | 961,600 |
| 2021/03/08 | 3,225 | 3,285 | 3,190 | 3,240 | +75 | +2.4% | 682,700 |
| 2021/03/05 | 3,195 | 3,230 | 3,125 | 3,165 | -15 | -0.5% | 947,700 |
| 2021/03/04 | 3,135 | 3,230 | 3,115 | 3,180 | +45 | +1.4% | 1,504,700 |
| 2021/03/03 | 3,025 | 3,140 | 2,980 | 3,135 | +187 | +6.3% | 1,912,000 |
| 2021/03/02 | 2,920 | 2,960 | 2,879 | 2,948 | -2 | -0.1% | 1,232,700 |
| 2021/03/01 | 2,999 | 3,015 | 2,918 | 2,950 | -18 | -0.6% | 844,600 |
| 2021/02/26 | 3,020 | 3,025 | 2,930 | 2,968 | -67 | -2.2% | 1,291,800 |
| 2021/02/25 | 3,150 | 3,150 | 3,020 | 3,035 | -45 | -1.5% | 1,002,900 |
| 2021/02/24 | 3,115 | 3,125 | 3,055 | 3,080 | -5 | -0.2% | 1,143,700 |
| 2021/02/22 | 3,165 | 3,165 | 3,045 | 3,085 | -70 | -2.2% | 843,600 |
| 2021/02/19 | 3,185 | 3,230 | 3,115 | 3,155 | -95 | -2.9% | 1,187,300 |
| 2021/02/18 | 3,290 | 3,305 | 3,240 | 3,250 | -25 | -0.8% | 614,400 |
| 2021/02/17 | 3,300 | 3,310 | 3,255 | 3,275 | +20 | +0.6% | 795,500 |
| 2021/02/16 | 3,305 | 3,320 | 3,220 | 3,255 | +15 | +0.5% | 1,104,100 |
| 2021/02/15 | 3,135 | 3,240 | 3,135 | 3,240 | +115 | +3.7% | 653,300 |
| 2021/02/12 | 3,145 | 3,145 | 3,055 | 3,125 | +20 | +0.6% | 729,800 |
| 2021/02/10 | 3,055 | 3,110 | 3,035 | 3,105 | +25 | +0.8% | 956,700 |
| 2021/02/09 | 3,115 | 3,115 | 3,045 | 3,080 | -105 | -3.3% | 930,600 |
| 2021/02/08 | 3,185 | 3,255 | 3,160 | 3,185 | -15 | -0.5% | 1,243,600 |
| 2021/02/05 | 3,060 | 3,230 | 3,050 | 3,200 | +175 | +5.8% | 1,469,800 |
| 2021/02/04 | 3,045 | 3,075 | 3,020 | 3,025 | -65 | -2.1% | 630,900 |
| 2021/02/03 | 3,115 | 3,145 | 3,065 | 3,090 | +25 | +0.8% | 842,800 |
| 2021/02/02 | 3,155 | 3,155 | 3,065 | 3,065 | -120 | -3.8% | 792,300 |
| 2021/02/01 | 3,105 | 3,195 | 3,090 | 3,185 | +85 | +2.7% | 797,500 |
| 2021/01/29 | 3,060 | 3,165 | 3,030 | 3,100 | +40 | +1.3% | 1,272,800 |
| 2021/01/28 | 3,030 | 3,095 | 3,005 | 3,060 | +20 | +0.7% | 873,200 |
| 2021/01/27 | 3,010 | 3,070 | 3,000 | 3,040 | +82 | +2.8% | 1,318,900 |
1001～
1050
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 217,400円 | -3.5% | -11.3% | 2.76% | 19.97倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 135,300円 | +0.9% | +380.2% | 5.76% | 18.63倍 | 1.60倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 220,700円 | +20.9% | +10.6% | 2.99% | 10.43倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 388,100円 | +1.7% | -2.9% | 4.12% | 25.46倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 150,100円 | +0.6% | +43.3% | 5.33% | 10.52倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
